Genome-Wide Association Study in Acute Tubulointerstitial Nephritis. Issue 5 (2nd May 2023)

• Record Type: Journal Article
• Authors: Zhou, Xu-Jie; Su, Tao; Xie, Jingyuan; Xie, Qiong-Hong; Wang, Li-Zhong; Hu, Yong; Chen, Gang; Jia, Yan; Huang, Jun-Wen; Li, Gui; Liu, Yang; Yu, Xiao-Juan; Nath, Swapan K.; Tsoi, Lam C.; Patrick, Matthew T.; Berthier, Celine C.; Liu, Gang; Wang, Su-Xia; Xu, Huji; Chen, Nan; Hao, Chuan-Ming; Zhang, Hong; Yang, Li
• Is Part Of: Journal of the American Society of Nephrology. Volume 34:Issue 5(2023)
• Page Start: 895
• Page End: 908
• Publication Date: 2023-05-02
• Subjects: acute renal failure -- clinical immunology -- renal biopsy -- molecular genetics -- acute tubulointerstitial nephritis -- genome-wide association study
• DOI: 10.1681/ASN.0000000000000091
• Languages: English
• ISSNs: 1046-6673

Abstract

Abstract : Abstract : Significance Statement: Polymorphisms of HLA genes may confer susceptibility to acute tubulointerstitial nephritis (ATIN), but small sample sizes and candidate gene design have hindered their investigation. The first genome-wide association study of ATIN identified two significant loci, risk haplotype DRB1*14-DQA1*0101-DQB1*0503 (DR14 serotype) and protective haplotype DRB1*1501-DQA1*0102-DQB1*0602 (DR15 serotype), with amino acid position 60 in the peptide-binding groove P10 of HLA–DR β 1 key. Risk alleles were shared among different causes of ATIN and HLA genotypes associated with kidney injury and immune therapy response. HLA alleles showed the strongest association. The findings suggest that a genetically conferred risk of immune dysregulation is part of the pathogenesis of ATIN. Background: Acute tubulointerstitial nephritis (ATIN) is a rare immune-related disease, accounting for approximately 10% of patients with unexplained AKI. Previous elucidation of the relationship between genetic factors that contribute to its pathogenesis was hampered because of small sample sizes and candidate gene design. Methods: We undertook the first two-stage genome-wide association study and meta-analysis involving 544 kidney biopsy-defined patients with ATIN and 2346 controls of Chinese ancestry. We conducted statistical fine-mapping analysis, provided functional annotations of significant variants, estimated single nucleotide polymorphism (SNP)-based heritability, and checked genotype and subphenotype correlations. Results: Two genome-wide significant loci, rs35087390 of HLA-DQA1 ( P =3.01×10 −39 ) on 6p21.32 and rs2417771 of PLEKHA5 on 12p12.3 ( P =2.14×10 −8 ), emerged from the analysis. HLA imputation using two reference panels suggested that HLA-DRB1*14 mainly drives the HLA risk association . HLA-DRB1 residue 60 belonging to pocket P10 was the key amino acid position. The SNP-based heritability estimates with and without the HLA locus were 20.43% and 10.35%, respectively. Different clinical subphenotypes (drug-related or tubulointerstitial nephritis and uveitis syndrome) seemed to share the same risk alleles. However, the HLA risk genotype was associated with disease severity and response rate to immunosuppressive therapy. Conclusions: We identified two candidate genome regions associated with susceptibility to ATIN. The findings suggest that a genetically conferred risk of immune dysregulation is involved in the pathogenesis of ATIN.